chloroquine has been researched along with flurazepam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ameisen, JC; Coppin, A; DeBels, F; Dewailly, E; Dzierszinski, F; Mortuaire, M; Slomianny, C; Tomavo, S | 1 |
1 review(s) available for chloroquine and flurazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for chloroquine and flurazepam
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Ligands of the peripheral benzodiazepine receptor are potent inhibitors of Plasmodium falciparum and Toxoplasma gondii in vitro.
Topics: Animals; Antimalarials; Chloroquine; Erythrocytes; Fibroblasts; Flurazepam; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hemeproteins; Humans; Isoquinolines; Ligands; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Toxoplasma | 2002 |